EDIT Q2 2021 Earnings — Editas Medicine, Inc. Revenue & Financial Results | Market Cap Arena

EDITEditas Medicine, Inc.

$260M

Q2 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$379,000-96.5% YoY

Gross Profit

-$33M-8805.8% margin

Operating Income

-$55M-14617.7% margin

Net Income

-$55M-14579.4% margin

EPS (Diluted)

$-0.81

QoQ Revenue Growth

-94.2%

Cash Flow

Operating Cash Flow

-$39M

Free Cash Flow

-$42M

Stock-Based Comp.

$14M

Balance Sheet

Total Assets

$756M

Total Liabilities

$143M

Stockholders' Equity

$613M

Cash & Equivalents

$338M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$379,000	$11M	-96.5%
Gross Profit	-$33M	-$17M	-93.4%
Operating Income	-$55M	-$31M	-76.8%
Net Income	-$55M	-$24M	-134.4%